SPARTHA Medical

Name

SPARTHA Medical

Legal name

Spartha Medical SAS

Website

https://sparthamedical.eu

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Antimicrobial Medical Device Coatings

NAICS

Paint and Coating Manufacturing (32551)

SIC

Paints, Varnishes, Lacquers, Enamels & Allied Prods (2851)

akta.pro primary industry

Industrial & Protective Coatings (IMAEAGAB)

akta.pro secondary industry

Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating) (IMAIAKAM)

Keywords

• Antimicrobial coatings
• Medical device coatings
• Biocompatible surface treatments
• Infection prevention solutions
• Polyelectrolyte multilayer films

Headquarters

HQ city

Strasbourg

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Coating Technology Licensing: Licensing of patented coating technology to medical device manufacturers, cosmetics companies, and other industrial partners. Co-development and white-label arrangements through spartha|SHIELD+ program.
2. Laboratory Testing Services: Comprehensive testing services including antimicrobial testing, contamination testing, coating resistance testing, in vitro testing, biocompatibility testing, cytotoxicity testing, sterilization testing, accelerated aging testing, and microbiological testing.
3. Antiviral and Antimicrobial Spray: Consumer/product spray solution free of alcohol and chlorine derivatives, providing protective layer against bacterial and viral contamination for various surfaces and skin applications.
4. Customized Implant Coatings: Personalized antimicrobial and anti-regenerating coatings for medical implants including cochlear, orthopedic and dental implants, addressing patient-specific needs through immunoprofiling.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

SPARTHA Medical designs, produces and markets multifunctional bio||intelligent coatings based on supramolecular polyelectrolyte multilayer (polyarginine/hyaluronic acid) technology that provide antimicrobial, antiviral and anti-inflammatory activity on contact. The company offers customized coatings for medical devices and implants (cochlear, orthopedic, dental), plus the spartha|SHIELD+ co-development/licensing program, AIC AI-driven tailored coatings, the protect|ION handheld applicator, an antiviral/antimicrobial spray, immunoprofiling diagnostics, and a full laboratory testing service suite.

Product overview

SPARTHA Medical is a deep-tech BioTech company that designs, produces, and markets innovative multifunctional solutions based on bio||intelligent coatings. The core offering centers on spartha|SHIELD+, their proprietary active interface coating platform, and the AIC (Active Interface Coating) system that uses machine learning to tailor coatings to specific product needs. The product portfolio includes protect|ION, a handheld medical device for applying antimicrobial membranes in surgical settings, and an antiviral/antimicrobial spray. The company offers laboratory testing services and co-development partnerships to help clients integrate coatings into medical devices, cosmetics, textiles, and consumer products. All coatings are based on natural biopolymers with antimicrobial, antiviral, and anti-inflammatory properties while preventing bacterial resistance.

Differentiator

Problem solved

Functional benefit

Brands

• spartha|SHIELD+: Strategic co-development initiative for integrating advanced active interface technology into various products across industries
• AIC Active Interface Coating
• protect|ION

Products and services

• spartha|SHIELD+
• AIC Active Interface Coating
• protect|ION Innovative handheld medical device that applies Spartha's antimicrobial membrane technology at the point of care. Designed for facial reconstruction in oncology and wound care, providing protection against hospital-acquired infections and supporting wound healing in surgical settings.
• Antiviral and Antimicrobial Spray
• Personalized Antimicrobial Coatings
• Laboratory Testing Services
• Immunoprofiling Services
• Co-Development Services

Quantifiable outcome

• 4.1 million euros EIC Accelerator funding secured for clinical trials
• +3 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature9 records

Partnerships

17 partnerships are on record, tiered core, flagship and minor.

• 3DEUS Dynamics SAScoreStrategic or Co-development Partner · 1 April 2025Eurostars-supported 4D-EASLEE project for next-generation CRM pouch for pacemakers. Spartha provides antimicrobial coating technology; targeting US market first.
• Hylomorph AGcoreStrategic or Co-development Partner · 1 April 2025Swiss partner in 4D-EASLEE project developing bio||intelligent pro-healing sleeve for cardiac implantable electronic devices.
• TOXBOX Consortium (16 partners from 9 countries)flagshipStrategic or Co-development Partner · 1 January 2024EU-funded project developing automatic diagnostic system for toxicity testing. Spartha Medical serves as scientific coordinator. 4-year project (2024-2028) promoting Safe and Sustainable by Design approach.
• Bio-Tune Consortium (6 European + 4 international partners)coreStrategic or Co-development Partner · 1 January 2024Focused on multifunctional coatings for medical devices. Completed in 2024, demonstrating versatility of coating technology in improving safety and effectiveness of medical implants.
• KISSMat Consortium (3 Grand Est partners)coreStrategic or Co-development Partner · 1 January 2024Regional collaboration developing antimicrobial solutions combining metallic nanoclusters with Spartha's biopolymer coatings for medical, cosmetic, and food sectors.
• LRGP/UMR 7274 CNRS, University of LorrainecoreStrategic or Co-development Partner · 1 January 2024KISSMat project partner (Laboratory of Reactions and Process Engineering) developing metallic nanocluster technology combined with biopolymer coatings.
• NET4MAT Consortium (13 collaborators from 7 countries)coreStrategic or Co-development Partner · 1 January 2023Revolutionizing food packaging with antimicrobial biodegradable plastics. Project aims to enhance food safety, extend shelf life, and reduce environmental impact.
• BIOFACE Project (7 partners)flagshipStrategic or Co-development Partner · 1 January 2023France 2030 RHU funded project for facial reconstruction in oncology. Led by Prof. Agnès Dupret-Bories at Toulouse University Hospital. Funding up to 4.395 million euros.
• PRCE Bioimtitis (6 partners)minorStrategic or Co-development Partner · 1 January 2023Dental implant project developing cell-adhesive coatings with antimicrobial properties for safer and more effective dental solutions.
• NOVA Project (14 partners from 9 countries)flagshipStrategic or Co-development Partner · 1 January 2022EU Horizon Europe funded project on next-generation bioactive coatings for textile industry. Spartha Medical is scientific coordinator. 7.5 million euros total budget.
• France BiotechcoreOthers · 1 January 2022Health innovation ecosystem network membership for turning innovative healthcare sector into successful industry, including deployment of multifunctional coatings for medical devices.
• PrestecoreTechnology or Integration · 1 January 2021AI/data science collaboration resulting in pioneering publication on using machine learning to predict coating properties. Collaboration published in Scientific Reports journal.
• SEMIAminorOthers · 1 January 2019Startup incubator where Spartha Medical was incubated after founding in 2019.
• BioValley FrancecoreOthers · 1 January 2019Competitiveness cluster network providing support and innovation acceleration. Spartha Medical is part of first organ-on-chip network in France structured by BioValley.
• PANBioRA Consortium (17 partners from 11 countries)coreStrategic or Co-development Partner · 1 January 2018EU-funded project on risk assessment for biomaterials (2018-2021). Overall budget of 7.992 million euros. Development of new methods and tools for personalized medicine applications.
• SATT ConectuscoreStrategic or Co-development Partner · 1 January 2016Technology transfer and development support from 2016-2018 for supramolecular coating technology. Primary channel for IP licensing from INSERM research.
• INSERM UMR1121 (Biomaterials/BioEngineering)coreTechnology or Integration · 1 January 2013Co-invention of antimicrobial coating technology; Dr. Philippe Lavalle serves as co-director and company's scientific co-director. Source of foundational patents and ongoing research collaboration.

Scale indicators15 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• DSM Biomedical: Dutch biomedical materials and coatings company (part of dsm-firmenich) offering a wide portfolio of biocompatible coatings and polymers. Broad incumbent in biomedical coatings serving implant and device OEMs.
• SurModics: US-listed company providing surface modification and coating technologies for medical devices and IVD. Broad incumbent in medical device coatings with deeper regulatory and OEM footprint than SPARTHA.
• PolyNovo: Australia-listed biomaterials company commercializing bioresorbable polymers for wound care and implant applications. Broad incumbent in biomedical polymer-based products, partially overlapping with SPARTHA's implant/wound care coating focus.

Direct peers

• Covalon Technologies: Canadian company commercializing antimicrobial coating and dressing technologies for medical devices and wound care. Comparable product categories (antimicrobial surface technologies) and customer base (hospitals and medical device manufacturers).
• Sciessent: US provider of antimicrobial and odor-control technologies (Agion, Active) integrated into textiles, medical devices, and consumer products. Direct comparable in cross-vertical antimicrobial coating licensing.
• BioInteractions: UK-based developer of antimicrobial and biocompatible coatings for medical devices, including implants and blood-contacting devices. Most direct head-to-head comparable for SPARTHA's medical device coating platform.
• Hydromer: US company specializing in hydrophilic and antimicrobial polymer coatings for medical devices, including catheters and guidewires. Direct competitor in functional polymer coatings for medical device OEMs.
• BioCote: UK-based antimicrobial additive and coating supplier serving consumer products, healthcare, and industrial markets. Comparable in cross-vertical antimicrobial coating licensing model, though more established and consumer-product focused.
• Harland Medical Systems: US provider of hydrophilic, antimicrobial, and drug-eluting coating services for medical device OEMs. Direct comparable in medical device coating services and OEM integration model.

Emerging players

• Avertica: Emerging antimicrobial coating developer focused on preventing healthcare-associated infections. Comparable niche focus on antimicrobial medical device coatings at an earlier commercialization stage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/SparthaMedical
• LinkedInlinkedin.com/in/nihal-engin-vrana-36761643
• Facebookfacebook.com/sparthamedical

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SPARTHA Medical